AU3392697A - (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof - Google Patents
(in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereofInfo
- Publication number
- AU3392697A AU3392697A AU33926/97A AU3392697A AU3392697A AU 3392697 A AU3392697 A AU 3392697A AU 33926/97 A AU33926/97 A AU 33926/97A AU 3392697 A AU3392697 A AU 3392697A AU 3392697 A AU3392697 A AU 3392697A
- Authority
- AU
- Australia
- Prior art keywords
- derivation
- vitro
- culture
- stem cells
- pluripotent stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/237—Oncostatin M [OSM]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66521796A | 1996-06-14 | 1996-06-14 | |
US08665217 | 1996-06-14 | ||
PCT/US1997/010316 WO1997047734A1 (en) | 1996-06-14 | 1997-06-13 | In vitro derivation and culture of primate pluripotent stem cells and therapeutic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3392697A true AU3392697A (en) | 1998-01-07 |
Family
ID=24669212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU33926/97A Abandoned AU3392697A (en) | 1996-06-14 | 1997-06-13 | (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3392697A (en) |
WO (1) | WO1997047734A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6271436B1 (en) | 1996-10-11 | 2001-08-07 | The Texas A & M University System | Cells and methods for the generation of transgenic pigs |
US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
WO2000034525A1 (en) * | 1998-12-09 | 2000-06-15 | Vistagen, Inc. | Toxicity typing using embryoid bodies |
US6635802B1 (en) | 2000-01-10 | 2003-10-21 | The Texas A&M University System | Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors |
US7455983B2 (en) | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
US7439064B2 (en) | 2000-03-09 | 2008-10-21 | Wicell Research Institute, Inc. | Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium |
US7005252B1 (en) * | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
US6458589B1 (en) * | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
US7473555B2 (en) | 2000-04-27 | 2009-01-06 | Geron Corporation | Protocols for making hepatocytes from embryonic stem cells |
US20020012905A1 (en) | 2000-06-14 | 2002-01-31 | Snodgrass H. Ralph | Toxicity typing using liver stem cells |
US8153424B2 (en) | 2001-10-03 | 2012-04-10 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US7588937B2 (en) | 2001-10-03 | 2009-09-15 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US6887706B2 (en) | 2001-10-03 | 2005-05-03 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells |
EP1446476A4 (en) | 2001-11-02 | 2005-01-26 | Wisconsin Alumni Res Found | Endothelial cells derived from primate embryonic stem cells |
MXPA04008824A (en) | 2002-03-15 | 2005-06-17 | Wicell Res Inst Inc | Method for generating primate trophoblasts. |
WO2007002086A2 (en) | 2005-06-22 | 2007-01-04 | Geron Corporation | Suspension culture of human embryonic stem cells |
WO2007143117A2 (en) | 2006-06-02 | 2007-12-13 | Geron Corporation | Differentiation of primate pluripotent cells to hepatocyte-lineage cells |
WO2008049161A1 (en) * | 2006-10-24 | 2008-05-02 | Adelaide Research & Innovation Pty Ltd | Method for the isolation of pluripotent cells from a pre-implantation embryo in a culture medium free from animal serum |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0380646B1 (en) * | 1988-08-04 | 1999-01-20 | Amrad Corporation Limited | Use of leukaemia inhibitory factor (lif) for the (in vitro) propagation of embryonic stem cells |
US5453357A (en) * | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US6432711B1 (en) * | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
WO1995016770A1 (en) * | 1993-12-17 | 1995-06-22 | Abs Global, Inc. | Ungulate preblastocyst derived embryonic stem cells and use thereof to produce cloned transgenic and chimeric ungulates |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
-
1997
- 1997-06-13 WO PCT/US1997/010316 patent/WO1997047734A1/en active Application Filing
- 1997-06-13 AU AU33926/97A patent/AU3392697A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997047734A1 (en) | 1997-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3392697A (en) | (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof | |
AU1644295A (en) | Cell culture substrates and methods of use | |
EP0812201A4 (en) | -i(IN VITRO) AMPLIFICATION OF STEM CELLS | |
AU2730497A (en) | Cryopreservation and extensive subculturing of human mesenchymal stem cells | |
AU5566396A (en) | Manipulation of plant cell and tissue cultures | |
AU9582398A (en) | Methods and devices for the long-term culture of hematopoietic progenitor cells | |
EP1650307A3 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
EP1398370A3 (en) | In-vitro micro-organs | |
AU2001226395A1 (en) | Techniques for growth and differentiation of human pluripotent stem cells | |
AU1119397A (en) | Ex vivo culture of stem cells | |
AU4336599A (en) | (in vitro) maintenance of hematopoietic stem cells | |
WO1999011758A3 (en) | Cultures of human cns neural stem cells | |
AU7832194A (en) | Gas permeable bioreactor and method of use | |
GB9213970D0 (en) | Improvements in and relating to tissue culture vessels | |
AU7769887A (en) | Apparatus and methods of culturing motile microorganisms | |
AU3783993A (en) | Culturing of hematopoietic stem cells and their genetic engineering | |
AU3557597A (en) | The isolation and culture of fetal cells from peripheral maternal blood | |
AU1478000A (en) | (in utero) transplantation of human mesenchymal stem cells | |
AU7468396A (en) | In vitro growth of functional islets of langerhans and in vivo uses thereof | |
PL322271A1 (en) | Novel defined mixtures of enzymes for use in growing cells and healing wounds | |
AU4378996A (en) | Cell compositions for use in transplantation and ex vivo gene therapy | |
AU2002230459A1 (en) | Cell culture apparatus and methods of use | |
AU2001217686A1 (en) | Method of establishing cultures of human dendritic cells and use thereof | |
AU2998300A (en) | Genetically altered mesenchymal stem cells and methods of use thereof | |
AU7954500A (en) | Method of in vitro culture of lymphocytes and gene therapy compositions |